Crescent Biopharma (CBIO) Assets (2013 - 2026)
Crescent Biopharma's Assets came in at $182.76 million for Q2 2026, up 16.1% from $157.43 million a year earlier but down 8.2% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Crescent Biopharma's Assets was $240.29 million, up 574.7% from FY2024.
- Assets carries a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
- Going back by year, Assets was $35.62 million in FY2024 (-21.4%), $45.32 million in FY2023 (-12.5%), $51.81 million in FY2022 (-45.1%) and $94.35 million in FY2021 (-33.9%).
- The five-year range for quarterly Assets is $5.99 million (Q1 2025) to $240.29 million (Q4 2025).
- Year-over-year, Assets increased in four of the last seven quarters, with growth averaging 248.8%.
- The fastest year-over-year change in Assets over five years came in Q3 2025 (growth of 780.8%), and the weakest in Q1 2025 (a decline of 82.5%).
- Business Quant data shows CBIO's Assets at $199.13 million (Q1 2026), $240.29 million (Q4 2025) and $138.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Crescent Biopharma | 403.30 Mn | -304.00 Mn | - | 182.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 182.76 Mn |
| Mar 31, 2026 | 199.13 Mn |
| Dec 31, 2025 | 240.29 Mn |
| Sep 30, 2025 | 138.27 Mn |
| Jun 30, 2025 | 157.43 Mn |
| Mar 31, 2025 | 5.99 Mn |
| Dec 31, 2024 | 35.62 Mn |
| Sep 30, 2024 | 15.70 Mn |
| Jun 30, 2024 | 24.42 Mn |
| Mar 31, 2024 | 34.20 Mn |
| Dec 31, 2023 | 45.32 Mn |
| Sep 30, 2023 | 53.20 Mn |
| Jun 30, 2023 | 61.82 Mn |
| Mar 31, 2023 | 68.92 Mn |
| Dec 31, 2022 | 51.81 Mn |
| Sep 30, 2022 | 55.96 Mn |
| Jun 30, 2022 | 65.04 Mn |
| Mar 31, 2022 | 81.46 Mn |
| Dec 31, 2021 | 94.35 Mn |
| Sep 30, 2021 | 107.94 Mn |
API Access
Crescent Biopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();